ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
4 |
06/08/20 |
06/08/20 |
ASX - By Stock
|
23K
|
13M
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
2 |
06/08/20 |
06/08/20 |
ASX - By Stock
|
23K
|
13M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
3 |
05/08/20 |
05/08/20 |
ASX - By Stock
|
23K
|
13M
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
3 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
23K
|
13M
|
3
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Quarterly Activities Report & Appendix 4C - 30 June 2020
|
|
tealblue
|
6 |
3.9K |
7 |
23/07/20 |
23/07/20 |
ASX - By Stock
|
6
|
3.9K
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
4 |
21/07/20 |
21/07/20 |
ASX - By Stock
|
23K
|
13M
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
3 |
21/07/20 |
21/07/20 |
ASX - By Stock
|
23K
|
13M
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
17 |
21/07/20 |
21/07/20 |
ASX - By Stock
|
23K
|
13M
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L
|
|
tealblue
|
854 |
431K |
3 |
21/07/20 |
21/07/20 |
ASX - By Stock
|
854
|
431K
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
4 |
17/07/20 |
17/07/20 |
ASX - By Stock
|
23K
|
13M
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
2 |
17/07/20 |
17/07/20 |
ASX - By Stock
|
23K
|
13M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
2 |
17/07/20 |
17/07/20 |
ASX - By Stock
|
23K
|
13M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
4 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
23K
|
13M
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
3 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
23K
|
13M
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
0 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
23K
|
13M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
3 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
23K
|
13M
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
3 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
23K
|
13M
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
1 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
1 |
15/07/20 |
15/07/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
5 |
15/07/20 |
15/07/20 |
ASX - By Stock
|
23K
|
13M
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
0 |
14/07/20 |
14/07/20 |
ASX - By Stock
|
23K
|
13M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
3 |
14/07/20 |
14/07/20 |
ASX - By Stock
|
23K
|
13M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
tealblue
|
5.5K |
2.7M |
7 |
14/07/20 |
14/07/20 |
ASX - By Stock
|
5.5K
|
2.7M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
tealblue
|
5.5K |
2.7M |
2 |
14/07/20 |
14/07/20 |
ASX - By Stock
|
5.5K
|
2.7M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
1 |
12/07/20 |
12/07/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
4 |
12/07/20 |
12/07/20 |
ASX - By Stock
|
23K
|
13M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast's licensee Takeda (Alofisel®) appears to score a big win in Spanish Covid-19 trial
|
|
tealblue
|
12 |
12K |
5 |
11/07/20 |
11/07/20 |
ASX - By Stock
|
12
|
12K
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
5 |
10/07/20 |
10/07/20 |
ASX - By Stock
|
23K
|
13M
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
6 |
10/07/20 |
10/07/20 |
ASX - By Stock
|
23K
|
13M
|
6
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
2 |
10/07/20 |
10/07/20 |
ASX - By Stock
|
23K
|
13M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
msb and bot trading
|
|
tealblue
|
11 |
2.9K |
2 |
10/07/20 |
10/07/20 |
ASX - By Stock
|
11
|
2.9K
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
4 |
10/07/20 |
10/07/20 |
ASX - By Stock
|
23K
|
13M
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
3 |
10/07/20 |
10/07/20 |
ASX - By Stock
|
23K
|
13M
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
4 |
10/07/20 |
10/07/20 |
ASX - By Stock
|
23K
|
13M
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
2 |
10/07/20 |
10/07/20 |
ASX - By Stock
|
23K
|
13M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
3 |
09/07/20 |
09/07/20 |
ASX - By Stock
|
23K
|
13M
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
6 |
09/07/20 |
09/07/20 |
ASX - By Stock
|
23K
|
13M
|
6
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
3 |
09/07/20 |
09/07/20 |
ASX - By Stock
|
23K
|
13M
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
15 |
08/07/20 |
08/07/20 |
ASX - By Stock
|
23K
|
13M
|
15
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
8 |
05/07/20 |
05/07/20 |
ASX - By Stock
|
23K
|
13M
|
8
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
7 |
02/07/20 |
02/07/20 |
ASX - By Stock
|
23K
|
13M
|
7
|
|
ASX - By Stock
|
TLX |
Re:
Ann: FDA grants breakthrough designation for TLX250-CDx product
|
|
tealblue
|
17 |
6.5K |
4 |
01/07/20 |
01/07/20 |
ASX - By Stock
|
17
|
6.5K
|
4
|
|
Charts
|
NXS |
Re:
Charts NXS
|
|
tealblue
|
932 |
1.1M |
0 |
01/07/20 |
01/07/20 |
Charts
|
932
|
1.1M
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Update on New Drug Application for Prostate Cancer Imaging
|
|
tealblue
|
10 |
4.5K |
1 |
01/07/20 |
01/07/20 |
ASX - By Stock
|
10
|
4.5K
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
1 |
29/06/20 |
29/06/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
4 |
26/06/20 |
26/06/20 |
ASX - By Stock
|
23K
|
13M
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
2 |
25/06/20 |
25/06/20 |
ASX - By Stock
|
23K
|
13M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
1 |
24/06/20 |
24/06/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
1 |
23/06/20 |
23/06/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
tealblue
|
23K |
13M |
1 |
23/06/20 |
23/06/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|